Search results
GSK plc (NYSE:GSK) Receives $47.00 Average Target Price from Brokerages
ETF DAILY NEWS· 5 hours agoShares of GSK plc (NYSE:GSK – Get Free Report) have received an average rating of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat ...
9,154 Shares in GSK plc (NYSE:GSK) Bought by Virtu Financial LLC
ETF DAILY NEWS· 4 days agoVirtu Financial LLC acquired a new position in shares of GSK plc (NYSE:GSK – Free Report) in the fourth quarter, according to its most recent 13F filing ...
AI Regulation Must Not Stifle Growth, GSK CEO Says
Barrons.com· 4 days agoGSK is betting on AI to boost innovation for its pipeline as investor concerns cloud over the company's research-and-development productivity, but a...
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters via AOL· 4 days agoA bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued...
NBC Securities Inc. Has $1.43 Million Stock Holdings in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoThe firm owned 33,335 shares of the pharmaceutical company’s stock after selling 562 shares during the quarter. NBC Securities Inc.’s holdings in GSK were ...
GSK plc (NYSE:GSK) Shares Acquired by First Hawaiian Bank
ETF DAILY NEWS· 4 days agoFirst Hawaiian Bank boosted its holdings in GSK plc (NYSE:GSK – Free Report) by 3.3% in the first quarter, according to the company in its most recent Form ...
Leo Wealth LLC Purchases New Shares in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 6 days agoLeo Wealth LLC purchased a new stake in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to the company in its most recent filing with ...
Cwm LLC Cuts Stock Holdings in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoCwm LLC trimmed its stake in shares of GSK plc (NYSE:GSK – Free Report) by 7.2% in the 1st quarter, according to its most recent disclosure with the SEC ...
Major drug companies cap asthma medication costs at $35 per month
WISN 12 Milwaukee· 2 days agoMajor pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks· 5 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face the FDA's partial clinical hold following the death of two patients.